Schreuder TCMA - Search Results

1

Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.

van den Berg EH, Douwes RM, de Meijer VE, Schreuder TCMA, Blokzijl H. van den Berg EH, et al. Among authors: schreuder tcma. Dig Liver Dis. 2018 Jan;50(1):68-75. doi: 10.1016/j.dld.2017.08.022. Epub 2017 Aug 12. Dig Liver Dis. 2018. PMID: 28935188

2

Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.

van den Berg EH, van Tienhoven-Wind LJ, Amini M, Schreuder TC, Faber KN, Blokzijl H, Dullaart RP. van den Berg EH, et al. Metabolism. 2017 Feb;67:62-71. doi: 10.1016/j.metabol.2016.11.002. Epub 2016 Nov 6. Metabolism. 2017. PMID: 28081779

3

Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.

van den Berg EH, Amini M, Schreuder TC, Dullaart RP, Faber KN, Alizadeh BZ, Blokzijl H. van den Berg EH, et al. PLoS One. 2017 Feb 2;12(2):e0171502. doi: 10.1371/journal.pone.0171502. eCollection 2017. PLoS One. 2017. PMID: 28152105 Free PMC article.

4

High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study.

Nass KJ, van den Berg EH, Faber KN, Schreuder TCMA, Blokzijl H, Dullaart RPF. Nass KJ, et al. Among authors: schreuder tcma. Metabolism. 2017 Jul;72:37-46. doi: 10.1016/j.metabol.2017.04.004. Epub 2017 Apr 13. Metabolism. 2017. PMID: 28641782

5

Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).

Saeed A, Dullaart RPF, Schreuder TCMA, Blokzijl H, Faber KN. Saeed A, et al. Among authors: schreuder tcma. Nutrients. 2017 Dec 29;10(1):29. doi: 10.3390/nu10010029. Nutrients. 2017. PMID: 29286303 Free PMC article. Review.

6

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group. van den Brand FF, et al. Clin Gastroenterol Hepatol. 2019 Apr;17(5):940-947.e2. doi: 10.1016/j.cgh.2018.09.046. Epub 2018 Oct 3. Clin Gastroenterol Hepatol. 2019. PMID: 30291909

7

Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis.

Bos S, van den Boom B, Kamphuisen PW, Adelmeijer J, Blokzijl H, Schreuder T, Lisman T. Bos S, et al. Thromb Haemost. 2019 Feb;119(2):246-253. doi: 10.1055/s-0038-1676954. Epub 2019 Jan 4. Thromb Haemost. 2019. PMID: 30609442

8

Anticoagulant activity of edoxaban in patients with cirrhosis.

Bos S, Schreuder T, Blokzijl H, Adelmeijer J, Lisman T, Kamphuisen PW. Bos S, et al. Blood. 2020 Sep 24;136(13):1561-1564. doi: 10.1182/blood.2020005319. Blood. 2020. PMID: 32458002 Free article. No abstract available.

9

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.

Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling AS, Harrison SA; NN9931-4296 Investigators. Newsome PN, et al. N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185364 Clinical Trial.

10

High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.

Schreuder TC, Gelderblom HC, Weegink CJ, Hamann D, Reesink HW, Devries JH, Hoekstra JB, Jansen PL. Schreuder TC, et al. Liver Int. 2008 Jan;28(1):39-46. doi: 10.1111/j.1478-3231.2007.01610.x. Epub 2007 Nov 21. Liver Int. 2008. PMID: 18031478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page